| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 528,471 | 667,576 | 405,904 | 301,905 | | Cost of Revenue | (37,060) | (191,101) | 228,161 | 71,891 | | | Gross Profit | 565,531 | 858,677 | 177,743 | 230,014 | | | Operating Expenses | | Research Development | (18,980) | 18,980 |
-
|
-
| | Selling General and Administrative | 557,835 | 627,659 | 69,917 | 867,680 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 26,676 | 212,038 | 107,826 | (637,666) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (5,303) | 5,303 |
-
| | Earnings Before Interest And Taxes | 275,382 | 206,735 | 113,129 | (637,666) | | Interest Expense | 100,352 | 84,407 | 63,947 | 95,125 | | Income Before Tax | 175,030 | 122,328 | 49,182 | (732,791) | | Income Tax Expense | 65,210 | 48,333 | 16,756 | (230,283) | | Minority Interest | (23,534) | (6,184) |
-
| 62,606 | | | | Net Income From Continuing Ops | 86,286 | 67,811 | 32,426 | (439,902) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 86,286 | 67,811 | 32,426 | (439,902) | | Preferred Stock And Other Adjustments |
-
| (5,911) | 5,911 |
-
| | | Net Income Applicable To Common Shares | $86,286 | $61,900 | $38,337 | ($439,902) |
|
0.01% Nasdaq 
Income Statement
